SAILIFE - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 4.1
| Stock Code | SAILIFE | Market Cap | 21,498 Cr. | Current Price | 1,014 ₹ | High / Low | 1,084 ₹ |
| Stock P/E | 64.2 | Book Value | 109 ₹ | Dividend Yield | 0.00 % | ROCE | 14.1 % |
| ROE | 11.0 % | Face Value | 1.00 ₹ | DMA 50 | 941 ₹ | DMA 200 | 873 ₹ |
| Chg in FII Hold | -1.09 % | Chg in DII Hold | 1.49 % | PAT Qtr | 104 Cr. | PAT Prev Qtr | 83.0 Cr. |
| RSI | 58.2 | MACD | 23.3 | Volume | 6,07,031 | Avg Vol 1Wk | 6,37,916 |
| Low price | 635 ₹ | High price | 1,084 ₹ | PEG Ratio | 0.27 | Debt to equity | 0.15 |
| 52w Index | 84.4 % | Qtr Profit Var | 103 % | EPS | 15.7 ₹ | Industry PE | 27.6 |
📊 Analysis: SAILIFE is trading at ₹1,014, above both its 50 DMA (₹941) and 200 DMA (₹873), showing strong upward momentum. RSI at 58.2 indicates healthy strength without being overbought, while MACD (23.3) confirms bullish momentum. Volume (6.07 lakh) is close to the 1-week average, suggesting steady intraday participation.
💡 Optimal Buy Price: Around ₹1,005–1,010 if support holds near ₹1,000.
🎯 Profit Exit Levels: ₹1,030–1,040 (first resistance), ₹1,060 (secondary resistance).
🛡️ Stop-Loss: ₹995 (below intraday support).
⏱️ If Already Holding: Consider exiting near ₹1,030–1,040 if momentum stalls. If price fails to sustain above ₹1,000 with weakening volume, exit early to protect gains.
✅ Positive
- Quarterly PAT surged to ₹104 Cr from ₹83 Cr (103% growth).
- DII holdings increased by 1.49%, showing strong domestic support.
- PEG ratio at 0.27 suggests attractive valuation relative to growth.
- 52-week performance shows 84.4% gain, reflecting strong investor confidence.
⚠️ Limitation
- High P/E of 64.2 compared to industry average of 27.6.
- Dividend yield is 0.00%, offering no income support.
- ROE at 11.0% is moderate compared to valuation.
📉 Company Negative News
- FII holdings decreased by 1.09%, showing reduced foreign investor interest.
📈 Company Positive News
- Quarterly profit doubled, showing strong earnings momentum.
- DII inflows reflect domestic institutional confidence.
- MACD positive, confirming bullish intraday momentum.
🏭 Industry
- Industry PE at 27.6, much lower than SAILIFE’s 64.2, suggesting sector peers are more attractively valued.
- Pharma & life sciences sector remains in growth phase, supported by rising healthcare demand.
🔎 Conclusion
SAILIFE shows strong bullish momentum with excellent quarterly profit growth and domestic support. Despite high valuation and lack of dividend yield, intraday signals are favorable. Suitable for intraday trades with tight stop-losses and profit booking near resistance levels.
Would you like me to extend this into a basket overlay scan with peers like Divi’s Lab, Biocon, and Laurus Labs to benchmark SAILIFE’s intraday strength against the broader pharma sector?